{"id":"W4319308236","doi":"10.1212/wnl.0000000000005345","title":"Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis","year":2018,"lang":"en","type":"review","venue":"Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba","funders":"American Academy of Neurology","keywords":"Glatiramer acetate; Medicine; Teriflunomide; Multiple sclerosis; Alemtuzumab; Ocrelizumab; Placebo; Systematic review; Adverse effect; Internal medicine; Natalizumab; Cladribine; Cochrane Library; Expanded Disability Status Scale; Oncology; Disease; MEDLINE; Randomized controlled trial; Fingolimod; Alternative medicine; Immunology; Pathology; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008042228,0.002539967,0.01222185,0.01007689,0.000688909,0.0027585,0.002346579,0.002185724,0.01245767],"category_scores_gemma":[0.03921246,0.001343166,0.01002366,0.008766789,0.000741271,0.003032031,0.001915747,0.001919808,0.00092642],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005068213,"about_ca_system_score_gemma":0.01201027,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009839946,"about_ca_topic_score_gemma":0.02375346,"domain_scores_codex":[0.9909595,0.003447774,0.002873401,0.0007450341,0.001693397,0.0002808882],"domain_scores_gemma":[0.9856024,0.007604942,0.004406373,0.0002009704,0.001887585,0.0002976934],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002158003,0.000009785696,0.0002912997,0.9680094,0.01014022,0.00004042735,0.00007403405,0.00007397703,0.00007382931,0.0001194908,0.00203459,0.01891702],"study_design_scores_gemma":[0.0006316216,0.0002556692,0.002764232,0.8819647,0.09468067,0.0002258542,0.0001238626,0.0001054375,0.0001151838,0.0002638665,0.01883031,0.00003850351],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006077966,0.9961455,0.0002197272,0.0003884956,0.0002188261,0.0009713896,0.001014009,0.00002316197,0.0004110362],"genre_scores_gemma":[0.01390256,0.9800322,0.001474405,0.001035161,0.0001838926,0.002238713,0.0007542529,0.00001146748,0.0003673566],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01245767,"threshold_uncertainty_score":0.04253191,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1591513686219583,"score_gpt":0.3659889685661996,"score_spread":0.2068375999442413,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}